Blue Trust’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Other funds holding MYGN
Blue Trust's MYGN Position: Q3 2026 in Review
Blue Trust held its Myriad Genetics (MYGN) position steady in Q3 2026 at 158 shares worth $681. The position accounts for ﹤0.01% of the portfolio, ranked #2247.
Blue Trust first reported a position in MYGN in Q2 2022 and has held it in 18 quarters since. The position peaked at $310K in Q3 2024. 129 funds tracked by Wall St. Rank hold MYGN as of Q3 2026.
- Blue Trust held 158 shares of Myriad Genetics worth $681 as of Q3 2026.
- Blue Trust left its Myriad Genetics share count unchanged in Q3 2026.
- Myriad Genetics made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2247 holding.
- Blue Trust first reported a position in Myriad Genetics in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Myriad Genetics position peaked at $310K in Q3 2024.
- 129 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.